ArticleNPJ breast cancer2021

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Andrea Gombos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.